A Study of LY3305677 in Healthy Participants

NCT02972645 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

66

Enrollment

INDUSTRY

Sponsor class

Conditions

Healthy

Interventions

DRUG: LY3305677
DRUG: Placebo

Sponsor

Eli Lilly and Company